Driessen et al. reported increased GRP78, CHOP, and ER stress-related protein disulfide isomerase (PDI) in PBMCs of MM patients receiving both nelfinavir and bortezomib [75]. The gene discussed is DDIT3; the disease is Miyoshi myopathy.